Rep. Upton To Hold FDA, Device Industry Y2K Compliance Hearing
This article was originally published in The Gray Sheet
Executive Summary
House Commerce/Oversight and Investigations Subcommittee Chairman Fred Upton (R-Mich.) is planning a year 2000 compliance hearing with testimony from FDA and medical device manufacturers.
You may also be interested in...
GAO Optimistic About FDA Y2K Readiness Measures For High-Risk Devices
The General Accounting Office has a higher level of confidence in year 2000 readiness of high-risk medical devices than it did roughly five months ago, GAO Civil Agencies Information Systems Accounting and Information Management Division Director Joel Willemssen said.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.